Kexing Biopharm Co Ltd
SSE:688136
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kexing Biopharm Co Ltd
SSE:688136
|
CN |
|
L
|
Lumos Diagnostics Holdings Ltd
ASX:LDX
|
AU |
|
Cigna Corp
NYSE:CI
|
US |
|
Pan Global Resources Inc
F:2EU
|
CA |
|
Nihon Kagaku Sangyo Co Ltd
TSE:4094
|
JP |
|
Perpetual Ltd
ASX:PPT
|
AU |
|
S
|
Somboon Advance Technology PCL
SET:SAT
|
TH |
|
A
|
Attendo AB (publ)
F:7AT
|
SE |
Intrinsic Value
Is Kexing Biopharm Co Ltd undervalued or overvalued?
See the intrinsic value estimate for Kexing Biopharm Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Kexing Biopharm Co Ltd looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with Kexing Biopharm Co Ltd’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Kexing Biopharm Does
Kexing Biopharm is a Chinese drug maker that develops, manufactures, and sells biopharmaceutical medicines, especially recombinant protein drugs. In plain terms, it makes lab-grown therapies that are used to treat diseases in areas like oncology, blood disorders, and immune-related conditions. The company combines research, manufacturing, and commercial sales under one roof.
- Headquarters
- China CN
- Employees
- 1 048
- IPO date
- Dec 14, 2020
Earnings Waterfall
Kexing Biopharm Co Ltd
The intrinsic value for Kexing Biopharm Co Ltd (688136) under the Base Case is hidden CNY.
Compared with the current market price of 19.55 CNY, the stock appears hidden.